These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7315359

  • 1. Cellular and humoral in vitro cytotoxicity against autologous bladder tumor cells in humans. Differences in autologous cytotoxicity against non-invasive and invasive transitional-cell tumors of the urinary bladder.
    Jacobsen F.
    Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):235-9. PubMed ID: 7315359
    [Abstract] [Full Text] [Related]

  • 2. Complement-dependent in vitro cytotoxicity against autologous invasive bladder tumor cells in humans. Evaluation of the possible role of naturally-occurring antibodies in complement-dependent cytotoxicity.
    Jacobsen F.
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):297-302. PubMed ID: 7315361
    [Abstract] [Full Text] [Related]

  • 3. Increase of the in vitro complement-dependent cytotoxicity against autologous invasive human bladder tumor cells by neuraminidase treatment.
    Jacobsen F.
    Acta Pathol Microbiol Immunol Scand C; 1982 Jun; 90(3):187-92. PubMed ID: 7113706
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
    Troye M, Vilien M, Pape GR, Perlmann P.
    Int J Cancer; 1980 Jan 15; 25(1):33-43. PubMed ID: 7399743
    [Abstract] [Full Text] [Related]

  • 5. Lymphocyte cytotoxicity against autologous bladder tumor cells in humans, investigated by use of a chromium-51 release assay.
    Jacobsen F.
    Acta Pathol Microbiol Scand C; 1981 Jun 15; 89(3):175-80. PubMed ID: 7315355
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
    Carballido JA, Moltó LM, Manzano L, Olivier C, Salmerón OJ, Alvarez de Mon M.
    Cancer; 1993 Sep 01; 72(5):1743-8. PubMed ID: 8348503
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer.
    Mizutani Y, Okada Y, Yoshida O, Bonavida B.
    Cancer Biother Radiopharm; 1996 Dec 01; 11(6):385-91. PubMed ID: 10851499
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HLA antigen expression on urothelial cells: detection by antibody-dependent cell-mediated cytotoxicity.
    O'Toole CM, Tiptaft RC, Stevens A.
    Int J Cancer; 1982 Apr 15; 29(4):391-5. PubMed ID: 7085129
    [Abstract] [Full Text] [Related]

  • 18. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 15; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.
    Tsujihashi H, Matsuda H, Uejima S, Akiyama T, Kurita T.
    J Urol; 1988 Oct 15; 140(4):890-4. PubMed ID: 3262173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.